AMT
37
-2
BMY
74
5
EMR
65
-8
AVGO
38
-25
BA
42
4
CVS
39
-11
CMCSA
42
8
CHD
37
2
BBY
45
-4
DHR
66
-4
AA
67
-5
VIX
25
3
CNX
52
-8
AMP
73
-3
ADSK
58
-4
AMAT
49
-6
AAL
51
-2
CL
59
3
EMC
60
-12
CI
52
3
AMT
37
-2
BMY
74
5
EMR
65
-8
AVGO
38
-25
BA
42
4
CVS
39
-11
CMCSA
42
8
CHD
37
2
BBY
45
-4
DHR
66
-4
AA
67
-5
VIX
25
3
CNX
52
-8
AMP
73
-3
ADSK
58
-4
AMAT
49
-6
AAL
51
-2
CL
59
3
EMC
60
-12
CI
52
3
Financhill
Back

Critical Metals Corp. Vs. Nektar Therapeutics Sector Stock Comparison

Sell
32

CRML
Critical Metals Corp.

Last Price:
$9.17
Seasonality Move:
-72.67%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Sell
32
Critical Metals Corp. (CRML) is a Sell

Is Critical Metals Corp. a Buy, Sell or Hold?

  • The current Critical Metals Corp. [CRML] share price is $9.18. The Score for CRML is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • CRML is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRML Stock Price Chart

What is Critical Metals Corp.'s stock price today?

  • The Critical Metals Corp. share price today is $9.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRML is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

CRML Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 48.32 Sell
Chaikin Money Flow: -4368187 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.7 - 9.88) Buy
Bollinger Bands (100): (4.15 - 13.39) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

CRML Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.5 Sell
20-day SMA: 8.51 Buy
50-day SMA: 11.83 Sell
200-day SMA: 5.44 Buy
8-day EMA: 9.25 Sell
20-day EMA: 9.26 Sell
50-day EMA: 9.69 Sell
200-day EMA: 7.48 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Critical Metals Corp. Earnings Growth & CRML Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Critical Metals Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):